ALB and cancer: The fibrinogen to albumin ratio was commonly identified as a predictor of poor outcome and adverse events in patients with cardiovascular diseases, cancer, sepsis, and stroke, although not in neurosurgical ICU-admitted ICH patients [17,18,19,20,21,22,23,24,25,26].